Epinephrine and phenylephrine pretreatments for preventing postreperfusion syndrome during adult liver transplantation

Liver Transplantation

Volumn 18, Issue 12, 2012, Pages 1430-1439

  Ryu, Ho Geol ^a   Jung, Chul Woo ^a   Lee, Hyung Chul ^a   Cho, Youn Joung ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOPAMINE; HYPERTENSIVE AGENT; PHENYLEPHRINE; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART RATE; HOSPITALIZATION; HUMAN; HYPOTENSION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; POSTREPERFUSION SYNDROME; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ARTERIAL PRESSURE; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; EPINEPHRINE; FEMALE; HEART RATE; HOSPITAL MORTALITY; HUMANS; HYPOTENSION; INJECTIONS, INTRAVENOUS; LENGTH OF STAY; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PHENYLEPHRINE; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; TIME FACTORS; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 84870954039     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23511     Document Type: Article

References (25)

1. Aggarwal S, Kang Y, Freeman JA, Fortunato FL, Pinsky MR,. Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc 1987; 19 (suppl 3): 54 -55.
2. Bukowicka B, Akar RA, Olszewska A, Smoter P, Krawczyk M,. The occurrence of postreperfusion syndrome in orthotopic liver transplantation and its significance in terms of complications and short-term survival. Ann Transplant 2011; 16: 26 -30.
3. Chui AK, Shi L, Tanaka K, Rao AR, Wang LS, Bookallil M, et al. Postreperfusion syndrome in orthotopic liver transplantation. Transplant Proc 2000; 32: 2116 -2117.
4. Hilmi I, Horton CN, Planinsic RM, Sakai T, Nicolau-Raducu R, Damian D, at al. The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation. Liver Transpl 2008; 14: 504 -508.
5. Ryu HG, Jung CW, Lee CS, Lee J,. Nafamostat mesilate attenuates postreperfusion syndrome during liver transplantation. Am J Transplant 2011; 11: 977 -983.
6. Paugam-Burtz C, Kavafyan J, Merckx P, Dahmani S, Sommacale D, Ramsay M, et al. Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors. Liver Transpl 2009; 15: 522 -529.
7. Reich DL, Wood RK Jr, Emre S, Bodian CA, Hossain S, Krol M, Feierman D,. Association of intraoperative hypotension and pulmonary hypertension with adverse outcomes after orthotopic liver transplantation. J Cardiothorac Vasc Anesth 2003; 17: 699 -702.
8. Ulukaya S, Alper I, Aydin U, Kilic M,. Successful resuscitation of cardiac arrest due to postreperfusion syndrome during orthotopic liver transplantation: a case report. Transplant Proc 2007; 39: 3527 -3529.
9. Acosta F, Rodriguez MA, Sansano T, Contreras RF, Reche M, Roques V, et al. Influence of surgical technique on postreperfusion syndrome during liver transplantation. Transplant Proc 1999; 31: 2380 -2381.
10. Daniela K, Michael Z, Florian I, Silvia S, Estrella J, Doris D, Karl-Heinz T,. Influence of retrograde flushing via the caval vein on the post-reperfusion syndrome in liver transplantation. Clin Transplant 2004; 18: 638 -641.
11. Gruttadauria S, Cintorino D, Musumeci A, Arcadipane A, Burgio G, Clarizia S, et al. Comparison of two different techniques of reperfusion in adult orthotopic liver transplantation. Clin Transplant 2006; 20: 159 -162.
12. Findlay JY, Kufner RP,. Aprotinin reduces vasoactive medication use during adult liver transplantation. J Clin Anesth 2003; 15: 19 -23.
13. Koelzow H, Gedney JA, Baumann J, Snook NJ, Bellamy MC,. The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation. Anesth Analg 2002; 94: 824 -829.
14. Milroy SJ, Cottam S, Tan KC, Hilmi I, Oyesola B,. Improved haemodynamic stability with administration of aprotinin during orthotopic liver transplantation. Br J Anaesth 1995; 75: 747 -751.
15. Molenaar IQ, Begliomini B, Martinelli G, Putter H, Terpstra OT, Porte RJ,. Reduced need for vasopressors in patients receiving aprotinin during orthotopic liver transplantation. Anesthesiology 2001; 94: 433 -438.
16. Acosta F, Sansano T, Contreras RF, Reche M, Roques V, Beltran R, et al. Phenylephrine treatment of the postreperfusion syndrome in liver transplantation. Transplant Proc 1999; 31: 2373 -2374.
17. Acosta F, Sansano T, Contreras RF, Reche M, Beltran R, Roques V, et al. Atropine prophylaxis of the postreperfusion syndrome in liver transplantation. Transplant Proc 1999; 31: 2377.
18. Cordoví de Armas L, Jiménez Paneque RE, Gala López B, Rápalo Romero EI, Añuez Castillo Y, Vallongo Menéndez MB,. Rapid and homogeneous reperfusion as a risk factor for postreperfusion syndrome during orthotopic liver transplantation. Rev Bras Anestesiol 2010; 60: 154 -161.
19. Aggarwal S, Kang Y, Freeman JA, Fortunato FL Jr, Pinsky MR,. Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. J Crit Care 1993; 8: 154 -160.
20. Moller S, Henriksen JH,. Cirrhotic cardiomyopathy. J Hepatol 2010; 53: 179 -190.
21. Mandell MS, Tsou MY,. Cardiovascular dysfunction in patients with end-stage liver disease. J Chin Med Assoc 2008; 71: 331 -335.
22. De Wolf AM, Begliomini B, Gasior TA, Kang Y, Pinsky MR,. Right ventricular function during orthotopic liver transplantation. Anesth Analg 1993; 76: 562 -568.
23. Krenn CG, Hoda R, Nikolic A, Greher M, Plöchl W, Chevtchik OO, Steltzer H,. Assessment of ventricular contractile function during orthotopic liver transplantation. Transpl Int 2004; 17: 101 -104.
24. Ripoll C, Catalina MV, Yotti R, Olmedilla L, Pérez-Peña J, Lo Iacono O, et al. Cardiac dysfunction during liver transplantation: incidence and preoperative predictors. Transplantation 2008; 85: 1766 -1772.
25. Ko JS, Kim GS, Gwak MS, Yang M, Kim HK, Shin BS, et al. Greater hemodynamic instability with histidine-tryptophan-ketoglutarate solution than University of Wisconsin solution during the reperfusion period in living donor liver transplantation. Transplant Proc 2008; 40: 3308 -3310.